What this test measures
Beta-2 glycoprotein 1 (β2GPI, also written B2GP1) is a plasma protein that binds phospholipids on cell surfaces. In antiphospholipid syndrome (APS), the immune system produces autoantibodies against β2GPI that drive a hypercoagulable state — patients clot unexpectedly in arteries, veins, or placental vessels.
This test measures the IgG class antibody. Together with anti-cardiolipin IgG/IgM and lupus anticoagulant, it forms the standard antiphospholipid antibody panel. The 2023 ACR/EULAR criteria classify high-positive anti-β2GPI IgG (> 40 U) as a major laboratory criterion for APS.
Why it matters
APS is an under-recognised cause of stroke in young adults, deep-vein thrombosis without obvious risk factors, recurrent miscarriage, late-pregnancy stillbirth, and severe pre-eclampsia. In Indian obstetric clinics, recurrent pregnancy loss after two or three miscarriages is one of the most common indications for APS screening. In rheumatology, APS is checked in any unexplained thrombotic event, especially in younger patients or those with SLE.
A positive anti-β2GPI IgG must persist on a repeat test at least 12 weeks later to be diagnostically meaningful — transient positives occur with infection and some drugs. Treatment for confirmed APS is long-term anticoagulation (warfarin for thrombotic APS; low-dose aspirin + low-molecular-weight heparin for obstetric APS).
How to prepare
No fasting required. Inform the lab if you are taking biotin supplements (which can interfere with some immunoassays) — stop biotin at least 48 hours before the test. Disclose any recent infection (acute infection can cause transient positive results) and any anticoagulant medication. The test should be repeated at least 12 weeks apart to confirm persistent positivity.
Markers & reference ranges
Reference ranges below are typical adult values. Your lab's reported range may differ slightly based on the assay platform and patient demographics — always read your report against the range printed on it.
| Marker | Normal range | If low | If high |
|---|---|---|---|
| Anti-β2 Glycoprotein 1 IgG (U/mL (GPI-U))[1][2][3] | Negative — assay-specific (often < 20 GPI-U) | Negative: does not support APS at the time of sampling. Repeat in 12 weeks if clinical suspicion is high — sometimes antibodies fluctuate. | 20 – 40 U: low positive — clinical significance uncertain; repeat in 12 weeks. > 40 U: medium-to-high positive — significant antibody; repeat in 12 weeks to confirm persistence. A persistently high anti-β2GPI IgG with a qualifying thrombotic event or pregnancy morbidity confirms APS. |
Antiphospholipid antibody panel — what each test adds
| Antibody | Role | When |
|---|---|---|
| Lupus anticoagulant (LA) | Functional clotting test — strongest single APS marker | All suspected APS |
| Anti-cardiolipin IgG / IgM | ELISA antibody | All suspected APS |
| Anti-β2 glycoprotein 1 IgG / IgM | ELISA antibody, most specific | All suspected APS |
| "Triple positive" (all three) | Highest thrombosis risk | Most aggressive anticoagulation |
Frequently asked questions
When should I be tested for antiphospholipid antibodies?
After an unexplained venous or arterial thrombosis (especially in young or otherwise low-risk patients), recurrent miscarriages (3 or more before 10 weeks, or 1 or more late-pregnancy loss), severe early pre-eclampsia, or as part of evaluating SLE.
Why do I need to repeat the test in 12 weeks?
Antiphospholipid antibodies can be transiently positive after infections (HIV, hepatitis C, syphilis, EBV) or with certain drugs. APS diagnosis requires persistent positivity — the same antibody high-positive on two samples at least 12 weeks apart.
What does "triple positive" mean?
Patients positive for all three APS antibodies (lupus anticoagulant + anti-cardiolipin + anti-β2GPI) have the highest risk of clotting and pregnancy loss. They generally need more aggressive long-term anticoagulation and obstetric care.
Is APS the same as SLE?
No, but they overlap. APS can occur alone (primary APS) or alongside SLE or other autoimmune disease (secondary APS). About 30% of SLE patients have antiphospholipid antibodies, though not all develop clinical APS.
How is APS treated?
Long-term anticoagulation. After a venous clot: warfarin lifelong (target INR 2.0–3.0). After arterial clot: warfarin (sometimes with aspirin). In pregnancy: low-molecular-weight heparin + low-dose aspirin. Direct oral anticoagulants (rivaroxaban, apixaban) are generally NOT recommended in triple-positive APS.
Can I get pregnant if I have APS?
Yes, with proper management. Most APS pregnancies with combined aspirin + heparin and close obstetric monitoring result in healthy babies. Without treatment, pregnancy loss rates are very high.
Will my anti-β2GPI IgG ever go away?
In primary APS the antibodies usually persist lifelong, sometimes fluctuating in titer. They may transiently disappear after immunosuppression or rarely after rituximab. Persistent antibody alone does not change treatment unless clinical events recur.
Related Immunology tests
Tests commonly ordered alongside BETA 2 GLYCOPROTEIN 1 - IGG, or that help interpret an unexpected result.
Sources & references
- NCBI StatPearls — Antiphospholipid Syndrome · accessed 2026-05-30T00:00:00.000Z
- ACR/EULAR 2023 APS Classification Criteria · accessed 2026-05-30T00:00:00.000Z
- Mayo Clinic Labs — Beta-2 Glycoprotein I Antibodies · accessed 2026-05-30T00:00:00.000Z
- NIH MedlinePlus — Antiphospholipid Antibody Syndrome · accessed 2026-05-30T00:00:00.000Z
Book with Zelnoo
Get your BETA 2 GLYCOPROTEIN 1 - IGG test done at home — transparent prices, NABL-accredited labs.
Zelnoo lets you compare diagnostic test prices across NABL-accredited labs in Mumbai & Thane, book a free home phlebotomist visit, and receive digital reports in 24–48 hours into a consent-first report vault. No subscriptions, no membership fees — pay only for the test you book.
Book BETA 2 GLYCOPROTEIN 1 - IGG now